Want to join the conversation?
$PFE said it will acquire AstraZeneca's development and commercialization rights to its late-stage small molecule anti-infectives business, mainly outside the US. Deal includes rights for Zavicefta, marketed agents Merrem/Meronem and Zinforo, and clinical development assets aztreonam-avibactam and CXL. The deal is expected to close in 4Q16.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!